All cancer types, Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 1
This trial looked at a drug called AZD3965 for people with cancer that had continued to grow despite treatment. It was for people with a or (not ).
The trial was supported by Cancer Research UK. It was open for people to join between 2013 and 2019. The team analysed the results in 2021.
Recruitment start: 22 February 2013
Recruitment end: 30 September 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Ruth Plummer
AstraZeneca
Cancer Research UK (Centre for Drug Development)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKD/12/004.
Last reviewed: 14 December 2021
CRUK internal database number: 7034
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
